Entry into a Material Definitive Agreement

ChronoScale Holdings Corporation — Form 8-K summary

Reporting context: This is a transaction-focused current report, not a periodic financial statement. It describes financing and data-center project arrangements announced in November 2026. The filing gives no clear comparable-period revenue, profit, operating cash flow, or margin figures.

Key financing and financial terms

  • Common stock placement: The Company expected to close a private placement at $8.00 per share for approximately 19.1 million shares and $153.0 million in gross proceeds. Proceeds are intended primarily for its Project capital commitment, including data-center construction and GPUs, and for general corporate purposes.
  • Series C preferred placement: The Company may seek up to $500 million under a four-year commitment, subject to conditions and caps. The initial put was expected to be $10 million. Puts are generally capped at $50 million each, one per seven calendar days, with no more than $50 million of stated value outstanding at a time. The filing does not establish that the full commitment will be funded.
  • APLD convertible note: The Company issued a $97 million unsecured note to its controlling stockholder, and the filing states the full amount was funded. It bears no interest, matures December 31, 2026, and, after stockholder approval becomes effective, automatically converts at $8.00 per share—approximately 12.1 million shares before any fractional-share treatment. The Company cannot prepay without APLD’s consent.
  • Partnership funding and debt: ChronoScale Member is to lend $220 million to the Project partnership through an unsecured convertible note. Of this, $200 million is designated for GPU purchases and $20 million for partnership general purposes. The note bears 8% annual interest, paid in kind monthly, and is expected to convert after HSR clearance into partnership units at $100 per unit, with accrued interest cancelled upon conversion.
  • Partnership term loan: Macquarie is to provide the partnership a $74.6875 million loan, bearing 10% annual interest paid in kind and maturing 90 days after closing. It is secured by substantially all partnership and subsidiary assets, including GPUs, and is non-recourse to ChronoScale and its subsidiaries outside the partnership. Proceeds will repay part of STN’s existing Macquarie obligations and cover transaction expenses.
  • Liquidity and funding exposure: Before qualified project financing covering at least 75% of the project budget, ChronoScale Member must fund additional amounts needed for the Project without a specified cap. These advances are repayable with interest from STN’s deferred contribution or, if insufficient, from distributable cash on a priority basis. STN’s remaining cash contribution is conditional on qualified project financing; if none occurs, STN is not required to fund that balance.

Project, revenue opportunity, and material changes

  • STN is contributing project-related contracts, assets, permits, a site leasehold interest, and a technology license to OD1 JV Holdings LLC in exchange for partnership units. The filing describes the initial STN contribution as valued at approximately $251.9 million, with an additional cash balance potentially due after qualifying financing. Following conversion of ChronoScale’s $220 million note, the parties are expected to hold 50% of the partnership’s common units each.
  • The partnership is expected to assume a GPU services agreement with a leading AI lab. Four tranches are planned: the first was expected in the fourth quarter of 2026 and the remaining tranches in the first half of 2027, subject to possible extensions. The agreement could provide up to $7.5 billion of total contract value over approximately six years, assuming full performance and delivery; this is a contractual opportunity, not reported revenue or guaranteed cash flow. A substantial portion of the first phase is backed by credit support from an investment-grade technology company.
  • The transaction creates a large new capital commitment and potential data-center services revenue opportunity; the filing provides no prior-period operating results against which to measure a financial change.

Equity terms, dilution, and governance

  • The Series C has a $1,000 stated value per share, ranks ahead of common stock in liquidation but behind debt, and generally has no voting rights except statutory and protective matters. Its conversion price is the greater of 95% of the lowest five-day VWAP and a floor initially set at $12, subject to a $25 initial ceiling. The Board may change the floor, but not below $3.60, or change the ceiling.
  • Series C holders have certain cash redemption rights, including for specified trading failures and, in some circumstances, sustained conversion restrictions under the Nasdaq share cap. These terms could create cash obligations for the Company.
  • The Company expects to issue a warrant to the AI-lab customer for up to 8,072,152 common shares at $0.01 per share, with vesting tied to tranche delivery and acceptance and a potential expansion agreement. It also expects to issue STN a warrant for up to 850,000 shares at $0.001 per share, subject to project milestones and STN funding.
  • Additional dilution may result from the APLD note conversion, the Series C conversion, warrants, and potentially shares issued to settle the STN note assignment. Nasdaq-related issuance caps apply; shares under the common stock placement have priority under the relevant caps.
  • Holders of approximately 95.7% of voting power approved the relevant issuances by written consent. The approval becomes effective 20 calendar days after the Information Statement is first sent or given to stockholders; it is not effective merely because consent was obtained.
  • ChronoScale Member is to manage the partnership and arrange project financing, subject to STN consent rights and specified removal triggers. Partnership distributions are generally pro rata but subject to priority payments, financing restrictions, and an incentive plan.

Registration, contingencies, and risks

  • The Company must file resale registration statements for the common placement shares and Series C conversion shares on specified schedules. Late or ineffective registration for the common placement can trigger liquidated damages of 1% of each purchaser’s investment per 30-day period, capped at 8%.
  • Closing of the project contribution and related financing, HSR clearance and conversion of the partnership note, the preferred-stock puts, registration effectiveness, and project delivery are subject to conditions and timing uncertainty.
  • Key disclosed risks include failure to obtain qualified project financing on acceptable terms, the uncapped pre-financing funding requirement, delayed or failed GPU tranche delivery, customer termination rights or lack of expansion, and HSR clearance not occurring before the partnership note matures.
  • The filing also describes related-party arrangements with controlling stockholder affiliates, including the APLD note and proposed STN note assignment. The APLD note was reviewed and approved by the Board’s related-party transactions committee.

Important facts for investors to verify

  • Whether the common placement, initial preferred-stock put, and project contribution closed as anticipated, and the actual proceeds received.
  • When the Information Statement is distributed and stockholder approval becomes effective, and the resulting share count and dilution from note conversions, preferred stock, warrants, and any note-assignment shares.
  • Whether HSR clearance occurs in time for the $220 million partnership note to convert before maturity, and whether qualified project financing is secured.
  • Whether the Project meets GPU delivery and acceptance milestones, and whether the customer agreement’s potential contract value translates into recognized revenue and collected cash.
  • The Company’s actual cash needs and obligations under the uncapped pre-financing funding commitment, Series C redemption terms, registration-rights damages, and project financing arrangements.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.